chrisvoncsefalvay/vaers-outcomes huggingface dataset:
high fever; aches; sort throat; chills; tremors; and pains; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number was not reported) via an unspecified route of administration on 16Feb2021 as single dose for covid-19 immunisation. Medical history included covid-19 from Oct2020 to an unknown date. The patient's concomitant medications were not reported. On unspecified date the patient experienced high fever, aches, sort throat, chills, tremors, and pains. 16Feb2021 was first dose of covid vaccine, she experienced the following side effects- sort throat, fever, aches and pains, chills, tremors. The second dose of covid vaccine is scheduled for 09Mar2021. She had a positive covid test in Oct2020. She heard from someone that if you had covid 19 in the past, you might not need to have the second dose of the vaccine. The patient underwent lab tests and procedures which included body temperature: high on unspecified date. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
there was pain for 4 days directly after the injection.  Then on 11th day after injection there was redness, puffiness, itchy, warmer to touch in an area the size of a fist around the injection site which lasted for 5 days - no pain
This spontaneous report was received from a 60 year old male physician, referring to himself. His concurrent conditions included allergy to rifampin. The patient's medical history included a prior case of shingles before receiving ZOSTAVAX, and he stated that this was "other than indicated in the prescribing information". The patient's concomitant therapies were not provided. On 25-APR-2017 (reported as "3 weeks ago"), the patient was vaccinated with an unspecified dose of ZOSTAVAX injection, 1 dose, subcutaneously (lot# and expiration date were not provided) for shingles prevention, reconstituted with sterile diluent (manufacturer unknown). On 26-APR-2017, the day after the vaccination, he developed an itching sensation at the injection site and mentioned that he did not have any redness or swelling at the injection site. The patient did not seek medical attention and no treatment was given for the adverse event. However, the patient recovered from injection site pruritus on an unspecified date in 2017. The causal relationship between ZOSTAVAX sterile diluent (manufacturer unknown), and injection site pruritus was not provided. Additional information has been requested.
High fever of above 101 F. with body ache, and prolonged fever that doesn't respond to medicine.
Progressive development of incapacitating fatigue, reactive hypoglycemia, IBS, chronic pain, degenerative disc disease, depression.
10mins after shot my mouth was tingly and my tongue felt big. I didnt have trouble breathing. Was told to take benadryl when i got home. Next day i had diarrhea and stomach cramps the whole day. Random days of stomach cramping has continues. Recently pain in right arm when extending right arm.
About a month after my 2nd vaccination I started feeling very tired with full body muscle and joint pain.  I have rheumatic disease and my doctor did recommend that I get the COVID vaccine.  In April; About a month after my 2nd vaccination I started feeling very tired with full body muscle and joint pain.  I have rheumatic disease and my doctor did recommend that I get the COVID vaccine.  In April; About a month after my 2nd vaccination I started feeling very tired with full body muscle and joint pain.  I have rheumatic disease and my doctor did recommend that I get the COVID vaccine.  In April; This is a spontaneous report from a contactable consumer (patient). A female non-pregnant patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN5318, Expiration date: Not reported), dose 2 intramuscularly administered in Arm Right on 16Feb2021 as a DOSE 2, SINGLE for covid-19 immunisation. The patient medical history included, drug hypersensitivity (Sulpha allergy) and rheumatic disorder reported as, I have rheumatic disease. There were no chronic conditions. Concomitant medications received within 2 weeks of vaccination included hydroxychloroquine and celecoxib (CELEBREX) both taken for an unspecified indication. The patient historical vaccine includes received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN5318), dose 1 via unspecified route of administration on Arm Right on 26Jan2021 as a DOSE 1, SINGLE for covid-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19 by Nasal Swab on Apr2021 that was negative. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that, on Mar2021, about a month after my 2nd vaccination I started feeling very tired with full body muscle and joint pain. I have rheumatic disease and my doctor did recommend that I get the covid vaccine, In April. It was reported that, about a month after my 2nd vaccination I started feeling very tired with full body muscle and joint pain. I have rheumatic disease and my doctor did recommend that I get the COVID vaccine. In April I had blood drain for testing of my ANA levels and CPR markers. All results came back in the normal range, but muscle and joint pain remained until roughly June. No treatment was received for the event. Events resulted in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included antinuclear antibody which was normal on Apr2021 and sars-cov-2 test which was negative on Apr2021. Outcome of all the muscle and joint pain were resolved in Jun2021 whereas, feeling very tired was resolved on an unspecified date in 2021.
rash all over the body; This spontaneous report was received from a physician via company representative and referred to a 15-year-old patient of unknown gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On an unknown date in 2022, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (anatomical location, strength, dose, route, lot number, and expiration date were not reported) for prophylaxis.  On an unknown date in 2022, the patient developed rash all over the body after receiving a dose of rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). The rash went away the next day.  The causality between the event and the suspect vaccine was considered unknown.
slight headache about 30 minutes after vaccines was administered ,rash on right thigh, on Saturday Jan. 9th around 9:30PM. Rash and itchiness went away that night.
Inflammation of left shoulder as result of flu vaccination. Symptoms showed the evening after vaccination. Patient received medical care 10 days after and received NSAID from MD. On and off he is still having symptoms with inflamed tendon.
nauseous; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseous) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (nauseous). At the time of the report, NAUSEA (nauseous) outcome was unknown. Not Provided          Treatment information not provided. Concomitant medications were not provided.
Swollen arm; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm) and HEADACHE (Headache). At the time of the report, PERIPHERAL SWELLING (Swollen arm) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
This is a spontaneous report from a contactable nurse via a Pfizer sales representative. A patient of unspecified age, ethnicity, and gender received TRUMENBA, via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date after use of the product, the patient experienced nausea and pain at the injection site. It was reported that the patient was okay. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.
Mild fatigue and a little numbness on the left side of my left eye and left corner of my mouth; Mild fatigue and a little numbness on the left side of my left eye and left corner of my mouth; Mild fatigue and a little numbness on the left side of my left eye and left corner of my mouth; Mild soreness and sensitvity at the site of injection; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA EYE (Mild fatigue and a little numbness on the left side of my left eye and left corner of my mouth), HYPOAESTHESIA ORAL (Mild fatigue and a little numbness on the left side of my left eye and left corner of my mouth), FATIGUE (Mild fatigue and a little numbness on the left side of my left eye and left corner of my mouth) and INJECTION SITE PAIN (Mild soreness and sensitvity at the site of injection) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA EYE (Mild fatigue and a little numbness on the left side of my left eye and left corner of my mouth), HYPOAESTHESIA ORAL (Mild fatigue and a little numbness on the left side of my left eye and left corner of my mouth), FATIGUE (Mild fatigue and a little numbness on the left side of my left eye and left corner of my mouth) and INJECTION SITE PAIN (Mild soreness and sensitvity at the site of injection). At the time of the report, HYPOAESTHESIA EYE (Mild fatigue and a little numbness on the left side of my left eye and left corner of my mouth), HYPOAESTHESIA ORAL (Mild fatigue and a little numbness on the left side of my left eye and left corner of my mouth), FATIGUE (Mild fatigue and a little numbness on the left side of my left eye and left corner of my mouth) and INJECTION SITE PAIN (Mild soreness and sensitvity at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatment information was reported.
Information has been received from a medical assistant concerning a 23 year old female who on 11-JUL-2008 was vaccinated with her dose of GARDASIL vaccine (yeast) (LOT# 660387/1967U). Concomitant therapy included GYNAZOLE and FEMCON. Approximately the following day on 12-JUL-2008, the patient experienced a generalized rash. The medical assistant also states that the patient began treatment with GYNAZOLE on 11-JUL-2008 for yeast infection. Subsequently, the patient recovered from generalized rash. Additional information has been requested.
No adverse effects reported.; One patient was administered an improperly stored dose of  M-M-R II; This spontaneous report was received from a Registered Nurse referring to a  4 year old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.  On 19-JUL-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) recombinant Human albumin (rHA)(Strength, route, dose, frequency, and anatomical location were unknown) wit lot # R014355 and expiration date 21-MAY-2020, reconstituted with properly stored sterile diluent.   The administered dose of the vaccine experienced total time and highest temperature above 9°C (9.0°C) Celsius degrees for 65 hours and total time and highest temperature above 9°C (9.0°C) for 63 hours and 15 minutes. min. There was no a digital data logger invloved, and no previous temperature excursion. No adverse effects were reported.
Admission for robotic LAR for colorectal cancer. Hospital admission was within 6 weeks of receiving the COVID-19 vaccine.
patient became dizzy almost immediately after the immunization (9:50am) she remained dizzy until she left the pharmacy at 11:53pm. No other symptoms. Patient refused medical treatment. She did call her PCP to see if her dr wanted to see her.  I called the patient twice since she left the pharmacy no answer.
This is a spontaneous report from a contactable nurses received via a Pfizer sales representative. A 66-year-old female patient started to receive PREVNAR 13, via an unspecified route of administration in the left deltoid on 14Mar2019 16:00 at 0.5 ml, single as preventive. Medical history included glaucoma open angle, high cholesterol, abnormal blood pressure, allergy to tetanus and uses blood thinner. Ongoing concomitant medication included lisinopril for blood pressure simvastatin for high cholesterol, ZOFRAN for glaucoma, hydrochlorothiazide, triamterene HCT AL for blood pressure, pravastatin for high cholesterol and ZIOPTAN for glaucoma, open angle. The patient previously took T-Dap in 2007 and experienced allergy. On 15Mar2019 (next morning after administration), the patient felt like she had the flu. The patient received the vaccine in her left deltoid and it was swollen and huge about the size of an orange at first. The patient reported that she felt like she had the flu all week. The area of swelling and redness spread to her elbow and chest wall and she still has a small hardened area at the injection sites that itches. The patient reported that her arm really hurt and took ALEVE all last weekend. The patient added that the area that was still hardened was about the size of a quarter. The redness over arm that came across chest has gone away. The patient has just a small red circle at the time of the report. The patient did not have anaphylactic reaction and did not feel well the whole weekend. The outcome of the event 'felt like she had the flu' was recovered on 17Mar2019, 'arm really hurt' recovered on 20Mar2019 and event 'did not feel well' recovered on unspecified date; all other events was recovering.
That evening I had a sore throat and did not feel well. I took less than a half dose of BENADRYL to help me sleep. I awoke at 5:15 AM with my heart rate at 111 beats per minute, verified on my Smart watch. I exercise regularly and have a resting heart rate about 65 or 70. My chest was hurting on the left side. I felt very fatigued all day and tried to exert a low amount of energy at my desk job. After I got home from work, I saw that I had red hives all over my front and back sides. I called a medical friend, who said to take BENADRYL and an antacid. I also took allergy medicine each day and each evening before bedtime for the next four days. The following days, my back was itchy.
Patient came in for third covid vaccine. She was late in getting her third one. It should have been given months before. Patient should have gotten the Pfizer Bivalent not the third Pfizer Covid vaccine. The bivalent for this age group was not available at the time the Covid vaccine was given.
4 month old patient was inadvertently given a dose of Kinrix for dose 2 of IPV and DTaP, though dose 1 was Pediarix.  All minimal intervals were met despite this, and patient did not experience any adverse reaction to the vaccine.
After about 10 hours, pain at injection site.  By 12 hours, pain is considerable, cannot move arm around without wincing.  Went to bed and woke up about 3 hours later (e.g. 15 hours after injection).  Suffering from full body aches, headache (even my teeth and eyes hurt), chills, uncontrolled shaking, followed by uncontrolled sweating, muscle spasms, nausea, severe pain at injection site, swollen and painful lymph node in left armpit.  Little to no sleep that night.  In a fog all day Sunday, low grade fever just below 100.  Went to bed early (around 8:30pm) with similar but reduced symptoms.  Pain at injection site has subsided by now.  Shakes and chills are far less but still there.  Still sweating, really bad body aches, headache, swollen and tender lymph node under left arm.  Challenge sleeping but did a little better.  Today, Monday, still in a serious fog.  No energy.  Other symptoms appear to be subsiding
After administration of 2 injections of Lymerix the pt developed chronic joint pain, arthritis theorized to be caused by the Lymerix vaccine. This joint pain has been unresponsive to physical therapy, cortisone injections. 60 day follow-up states that the doctor thinks the pt may have had a low level case of Lyme Disease prior to receiving the vaccine and the vaccine reactivated the disease. The follow up received on 6/14/01 states, "a 42 yea rold nurse from the hospital presenting wiht pain involving the left hip similar to what she's had in the past. She is anxious to get another injection because shehas activities planned that will involve a lot of walking and moving about. So, therefore, after examination continues to show that she is very tender over the lateral aspect of the left greater trochnter she is carefully injected using sterile technique with Depo Medrol and lidocaine into the point of maximum tenderness and distal proximal injecting to the bone and then backing off so as to interset the bursa with at least some of the injected materials. She understands we can't guarantee results and that recurrence might happen. I can't think of any good surgical options for her and I don't think x-rays are indicated because she has a full and normal range of motion otherwise. She is advised it may be very painful fo ra day or two. She will see mee prn. Pt did not have very good relief from the injection last time and her tenderness is not right over the superficial portion of hte trochanteric bursa but rather appears deeper in the area of the gluteal bursae. She is given a more superficial Xylocaine injection but still has pain on deep presure despite the anesthetic agent being in the more superficial area of the bursa. She is therefore treated with a spinal needle by injection of the gluteal bursae with DepoMedrol, Xylocaine, and Marcaine and hopefully this will work. She will let me know how she does. The pt was not helped by the Depo Medrol injection last time. Her tenderness is somewhat deep and slightly proximal to the tip of the trochanter and may involve the gluteal bursa. She is treated with Xylocaine injection first in the area of the rochanteric bursa and this still has tenderness deep. Therefore the Depo Medrol and Xylocaine and Marcaine are injected both into the trochanteric bursa as well as the gluteal bursa and she will be seen again prn. The pt has a good result following injection of the trocahnteric bursa of the left hip. She now has recurrence of her symptoms and has been treated again by Depo Medrol injection. She is warned that she might have to have resection of the bursa, but we will wait and see how she does."
I got my period after not having it for over 2 years. It was very heavy and lasted almost two weeks.
Information has been received from a registered nurse concerning a 5 year old male who on 5/15/00 was vaccinated with his first dose of MMR. Post vaccination, the patient developed a measles like rash and prolonged fever. Unspecified medical attention was sought. A titer was drawn and the child seroconverted for measles and rubella, but not for mumps. Subsequently, the patient recovered. Additional information has been requested.
mixing error-used twice to draw diluent from multi vial diluent to mix with covid vaccine
Muscle aches; joint pain; headache and my right arm hurt (was sore) and fatigue and none of these were incapacitating but they lingered for quite awhile. I rotated taking Ibuprofen and Tylenol.  I had a COVID test on the 11th.  It was th12th when I went to the doctor. About January 14th is when symptoms went away. Had second dose of vaccine on February 2nd.
1/10/22 Report to employer's employee health department, no symptoms listed. 1/20/22 Associated symptoms include rhinorrhea and a sore throat. Pertinent negatives include no chest pain, ear pain or shortness of breath.  Diagnosed with Covid-19 on 1/10. Continues to have residual cough that is not improving. Remains mostly dry but feels congestion in chest. Taking Mucinex, Dayquil/Nyquil and cough drops. Cough is nearly continuous. No fever or SOA. Cannot rest at night d/t cough. The following portions of the patient's history were reviewed and updated as appropriate: allergies, current medications, past family history, past medical history, past social history, past surgical history and problem list. Review of Systems: HENT: Positive for congestion, rhinorrhea, sore throat and trouble swallowing. Negative for ear discharge, ear pain, sinus pressure and sinus pain. Respiratory: Positive for cough, Negative for shortness of breath. Cardiovascular: Negative for chest pain. Physical Exam: Vitals and nursing note reviewed. Constitutional: Appearance: She is well-developed. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Heart sounds: Normal heart sounds. Pulmonary: Effort: Pulmonary effort is normal. Breath sounds: Wheezing and rhonchi present. Abdominal: General: Bowel sounds are normal. Palpations: Abdomen is soft. Musculoskeletal: General: Normal range of motion. Skin: General: Skin is warm and dry. Neurological: Mental Status: She is alert and oriented to person, place, and time. 1/20/22  methylPREDNISolone (MEDROL DOSPACK) 4 MG tablet; follow package directions. promethazine-dextromethorphan (PROMETHAZINE-DM) 6.25-15 MG/5ML syrup; Take 2.5-5 mLs by mouth four times daily as needed for Cough. benzonatate (TESSALON) 100 MG capsule; Take 1 capsule by mouth 3 (three) times daily as needed for Cough.
Sot was given at 1343, within 15 minutes site was red and itching with minor swelling.  within 20 minutes I began  coughing and feeling tightness in my chest/lungs.  After consulting the Nurses at the Vaccine site, I called my PTP and was told to go to ER.  I took 2 puffs of my Albuteral inhaler and drove myself to ER (about a mile).  I spent 3 hours in ER under observation where they did a blood test for multiple things that checked out fine, a Covid-19 test (negative) and listened to me hack for almost  2 hours.  I followed up with my PTP the next week, where she wasn't sure why I reacted the way I did as all lab work was normal.  She said to get the 2nd shot and see what happens.
Patient has redness, swelling, warmth and a lump at the site of the injection that started shortly after administration according to the patient and is noted on exam today. Started patient on antibiotic for possible cellulitis related to the injection.